Late anthracycline cardiotoxicity in patients treated for childhood acute lymphoblastic leukemia

Introduction: advances in the treatment of childhood acute lymphoblastic leukemia give a greater life expectancy for these patients. As the number of survivors increase, more long-term adverse effects are detected. Among the most frequent adverse effects stands late anthracycline cardiotoxicity (dox...

Full description

Bibliographic Details
Main Authors: Tamara Cedré Hernández, Liliana Martínez Cárdenas, Marta Beatriz García Caraballoso, Alejandro González Díaz, Guillermo González Ojeda, Alina Castillo Villocht
Format: Article
Language:Spanish
Published: Editorial Ciencias Médicas 2013-10-01
Series:Acta Médica del Centro
Subjects:
Online Access:http://www.revactamedicacentro.sld.cu/index.php/amc/article/view/4